Expertise in
25
conditions

Dr. Kruti R. Patel

Gastroenterology
1615 N US Hwy 75, Ste A, 
Sherman, TX 
Accepting New Patients
Expertise in
25
conditions
1615 N US Hwy 75, Ste A, 
Sherman, TX 

Overview

Kruti Patel is a Gastroenterologist practicing medicine in Sherman, Texas.

Dr. Patel is highly rated in 25 conditions, according to our data. Her clinical expertise encompasses Painful Swallowing, Swallowing Difficulty, Gastroesophageal Reflux Disease (GERD), and Diverticular Disease.

Dr. Patel is board certified in Gastroenterology- American Board Of Internal Medicine, Gastroenterology- American Board Of Internal Med/Gastroenterology, Internal Medicine- American Board Of Internal Med, and Internal Medicine- American Board Of Internal Medicine. She is actively involved in clinical research, co-authoring 10 peer reviewed articles and participating in 6 clinical trials. Dr. Patel is currently accepting new patients.

Specialties

Gastroenterology

Licenses

Internal Medicine in TX

Board Certifications

Gastroenterology- American Board Of Internal Medicine
Gastroenterology- American Board Of Internal Med/Gastroenterology
Internal Medicine- American Board Of Internal Med
Internal Medicine- American Board Of Internal Medicine

Fellowships

Gastroenterology, Ascension Genesys Hospital - 2021

Hospital Affiliations

Baylor Scott And White Surgical Hospital At Sherma
Wilson N Jones Regional Medical Center
Texoma Medical Center

Languages Spoken

English
Gujarati 

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Baylor Scott & White Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
FirstCare
  • HMO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Scott and White Health
  • HMO
  • POS
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

Texas Digestive Disease Consultants
1615 N US Hwy 75, Ste A, Sherman, TX 75092

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Randomized Phase III Trial of MEDI4736 (Durvalumab) as Concurrent and Consolidative Therapy or Consolidative Therapy Alone for Unresectable Stage 3 NSCLC
Randomized Phase III Trial of MEDI4736 (Durvalumab) as Concurrent and Consolidative Therapy or Consolidative Therapy Alone for Unresectable Stage 3 NSCLC
Enrollment Status: Active_not_recruiting
Publish Date: September 08, 2026
Intervention Type: Drug, Biological
Study Drugs: Carboplatin, Cisplatin, Durvalumab, Etoposide, Paclitaxel, Pemetrexed Disodium
Study Phase: Phase 3
A Randomized Phase III Study of Nivolumab After Combined Modality Therapy (CMT) in High Risk Anal Cancer
A Randomized Phase III Study of Nivolumab After Combined Modality Therapy (CMT) in High Risk Anal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Procedure, Biological, Other
Study Drug: Nivolumab
Study Phase: Phase 3
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 02, 2026
Intervention Type: Other, Procedure, Drug, Biological, Radiation
Study Drugs: Cisplatin, Nivolumab
Study Phase: Phase 2/Phase 3
TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 01, 2026
Intervention Type: Radiation, Other
Study Phase: Phase 3
RT CHARM: Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation With Breast Reconstruction
RT CHARM: Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation With Breast Reconstruction
Enrollment Status: Active_not_recruiting
Publish Date: February 24, 2026
Intervention Type: Other, Radiation
Study Phase: Phase 3
Nebulized Hypertonic Saline for Inpatient Use in Chronic Obstructive Pulmonary Disease
Nebulized Hypertonic Saline for Inpatient Use in Chronic Obstructive Pulmonary Disease
Enrollment Status: Completed
Publish Date: November 22, 2017
Intervention Type: Drug
Study Phase: Phase 4
View 5 Less Clinical Trials

10 Total Publications

Method qualification of an electrochemiluminescence assay to quantitate anti-FcεR1α autoantibodies: a case study of an antibody-based biomarker.
Method qualification of an electrochemiluminescence assay to quantitate anti-FcεR1α autoantibodies: a case study of an antibody-based biomarker.
Journal: Bioanalysis
Published: May 19, 2026
Similar Doctors
Expertise in
29
conditions
Dr. Marlyn J. Mayo
Gastroenterology
Expertise in
29
conditions
Dr. Marlyn J. Mayo
Gastroenterology
Referral may be required

University Of Texas Southwestern Medical Center

5323 Harry Hines Blvd, 
Dallas, TX 
 (58.6 miles away)
214-645-8600
Languages Spoken:
English
See accepted insurances

Marlyn Mayo is a Gastroenterologist practicing medicine in Dallas, Texas. Dr. Mayo is highly rated in 29 conditions, according to our data. Her clinical expertise encompasses Primary Biliary Cholangitis, Cholestasis, Cholangitis, Cirrhosis, and Liver Transplant.

Expertise in
11
conditions
Dr. Stuart J. Spechler
Gastroenterology
Expertise in
11
conditions
Dr. Stuart J. Spechler
Gastroenterology
Referral may be required

Select Specialty Hospital-Dallas Downtown

3500 Gaston Ave, 
Dallas, TX 
 (59.7 miles away)
214-865-2241
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Stuart Spechler is a Gastroenterologist practicing medicine in Dallas, Texas. Dr. Spechler is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Gastroesophageal Reflux Disease (GERD), Barrett Esophagus, Esophagitis, Endoscopy, and Colonoscopy.

Expertise in
26
conditions
Dr. Parvez S. Mantry
Gastroenterology | Hepatology
Expertise in
26
conditions
Dr. Parvez S. Mantry
Gastroenterology | Hepatology
Referral may be required
Before you request

MedHealth DBA Methodist Transplant Specialists

2821 E President George Bush Hwy, Ste 304, 
Richardson, TX 
 (45.4 miles away)
214-947-4400
Languages Spoken:
English, Hindi, Marathi, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Parvez Mantry is a Gastroenterologist and a Hepatologist practicing medicine in Richardson, Texas. Dr. Mantry is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Nonalcoholic Steatohepatitis (NASH), Hepatitis, Liver Failure, Liver Transplant, and Endoscopy. Dr. Mantry is board certified in Gastroenterology- American Board Of Internal Med. Dr. Mantry is currently accepting new patients.

Frequently Asked Questions about Dr. Kruti R. Patel

How do I make an appointment with Dr. Kruti R. Patel?

You can book an appointment with Dr. Kruti R. Patel by calling their office at 903-892-9179. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Kruti R. Patel a top-rated expert for Painful Swallowing?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Kruti R. Patel is classified as an Advanced expert for Painful Swallowing, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Kruti R. Patel specialize in?

While Dr. Kruti R. Patel is a Gastroenterology, they have specific expertise in Painful Swallowing, Swallowing Difficulty, and Gastroesophageal Reflux Disease (GERD). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gastroenterology.

Does Dr. Kruti R. Patel participate in research or clinical trials?

Yes. Dr. Kruti R. Patel has published 10 articles and abstracts on conditions like Painful Swallowing. You can view a list of Dr. Kruti R. Patel's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Kruti R. Patel accept my insurance?

Dr. Kruti R. Patel accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 903-892-9179 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Patel's expertise for a condition
ConditionClose
      View All 25 Advanced Conditions
      View All 60 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile